易華錄(300212.SZ):“基於全息感知的公安交通管控與協同指揮關鍵技術及應用”項目榮獲國家科學技術進步二等獎
格隆匯1月13日丨易華錄(300212.SZ)公佈,2020年1月10日,2019年度國家科學技術獎勵大會在北京召開。公司協同其他單位聯合申報的“基於全息感知的公安交通管控與協同指揮關鍵技術及應用”項目榮獲2019年度國家科學技術進步二等獎。
該項目主要負責人之一趙新勇,控股子公司華錄易雲科技有限公司總經理,同時獲得2019年度國家科學技術進步二等獎。
國家科學技術進步獎是科技領域最具權威性和影響力的獎項之一,代表了國內先進的科技創新水平。此次獲獎,是對公司技術進步和創新能力的充分肯定,有助於進一步提升公司的品牌影響力和產品的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.